Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement

Autor: Schoels, Mm, Van Der Heijde, D, Breedveld, Fc, Burmester, Gr, Dougados, M, Emery, P, Ferraccioli, Gianfranco, Gabay, C, Gibofsky, A, Gomez Reino, Jj, Jones, G, Kvien, Tk, Murakami, M, Murikama, Mm, Nishimoto, N, Smolen, Js

Publikováno v: Annals of the Rheumatic Diseases, 72(4), 583-589
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, Vol. 72, No 4 (2013) pp. 583-9

Background Suppression of the immunoinflammatory cascade by targeting interleukin 6 (IL-6) mediated effects constitutes a therapeutic option for chronic inflammatory diseases. Tocilizumab is the only IL-6 inhibitor (IL-6i) licensed for rheumatoid art

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dcd89f6b6a3c70daee2561a6377538e
https://hdl.handle.net/1887/98414

To DAPSA or not to DAPSA? That is not the question.

Autor: Schoels MM; Department of Rheumatology, Medical University of Vienna, Vienna, Austria., Smolen JS; Department of Rheumatology, Medical University of Vienna, Vienna, Austria., Aletaha D; Department of Rheumatology, Medical University of Vienna, Vienna, Austria.

Publikováno v: Annals of the rheumatic diseases [Ann Rheum Dis] 2019 Jul; Vol. 78 (7), pp. e61. Date of Electronic Publication: 2018 May 05.

Consensus-based recommendations for the use of biosimilars to treat rheumatological diseases.

Autor: Kay J; Division of Rheumatology, Department of Medicine, UMass Memorial Medical Center and University of Massachusetts Medical School, Worcester, Massachusetts, USA., Schoels MM; Department of Internal Medicine, Centre for Rheumatic Diseases, Hietzing Hospital, Vienna, Austria., Dörner T; Department of Medicine/Rheumatology and Clinical Immunology, Charité Universitätsmedizin and Deutsches Rheumaforschungszentrum (DRFZ), Berlin, Germany., Emery P; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, UK., Kvien TK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway., Smolen JS; Department of Internal Medicine, Centre for Rheumatic Diseases, Hietzing Hospital, Vienna, Austria.; Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria., Breedveld FC; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.

Publikováno v: Annals of the rheumatic diseases [Ann Rheum Dis] 2018 Feb; Vol. 77 (2), pp. 165-174. Date of Electronic Publication: 2017 Sep 02.

Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update.

Autor: Stoffer MA; Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria University of Applied Sciences for Health Professions Upper Austria, Linz, Austria., Schoels MM; Department of Internal Medicine, Centre for Rheumatic Diseases, Hietzing Hospital, Vienna, Austria., Smolen JS; Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria Department of Internal Medicine, Centre for Rheumatic Diseases, Hietzing Hospital, Vienna, Austria., Aletaha D; Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria., Breedveld FC; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands., Burmester G; Department of Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Free University and Humboldt University Berlin, Berlin, Germany., Bykerk V; Division of Rheumatology, Weill Cornell Medical College, Cornell University, Hospital for Special Surgery, New York, USA., Dougados M; Department of Rheumatology, Hôpital Cochin, Paris Descartes University, Assistance Publique-Hôpitaux de Paris; INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France., Emery P; Academic Unit of Musculoskeletal Disease, University of Leeds, Leeds, UK., Haraoui B; Rheumatic Disease Unit, University of Montreal, Montreal, Canada., Gomez-Reino J; Rheumatology Service and Department of Medicine, Hospital Clinico Universitario, Universidad de Santiago, Spain., Kvien TK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway., Nash P; Department of Medicine, University of Queensland, Brisbane, Australia., Navarro-Compán V; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands Department of Rheumatology, University Hospital La Paz, Madrid, Spain., Scholte-Voshaar M; Department of Psychology, Health and Technology, University of Twente, Enschede, The Netherlands., van Vollenhoven R; The Karolinska Institute, Stockholm, Sweden., van der Heijde D; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands., Stamm TA; Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria.

Publikováno v: Annals of the rheumatic diseases [Ann Rheum Dis] 2016 Jan; Vol. 75 (1), pp. 16-22. Date of Electronic Publication: 2015 May 19.

Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritis.

Autor: Schoels MM; 2nd Department of Internal Medicine, Center for Rheumatic Diseases, Hietzing Hospital, , Vienna, Austria., Braun J, Dougados M, Emery P, Fitzgerald O, Kavanaugh A, Kvien TK, Landewé R, Luger T, Mease P, Olivieri I, Reveille J, Ritchlin C, Rudwaleit M, Sieper J, Smolen JS, Wit Md, van der Heijde D

Publikováno v: Annals of the rheumatic diseases [Ann Rheum Dis] 2014 Jan; Vol. 73 (1), pp. 238-42. Date of Electronic Publication: 2013 Jun 05.